NCT00545337View on ClinicalTrials.gov

Glulisine + Lantus in Type I Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

Insuline glulisine

Trial Locations (1)

Unknown

Sanofi-Aventis, Kiev

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00545337 - Glulisine + Lantus in Type I Patients | Biotech Hunter | Biotech Hunter